Home » U.S. Bioanalytical Methods Guidance Defines Three Levels of Validation
U.S. Bioanalytical Methods Guidance Defines Three Levels of Validation
A U.S. Food and Drug Administration draft guidance on validating bioanalytical methods for evaluating drugs, their metabolites and biomarkers — techniques the agency calls “critical” for conducting successful clinical and nonclinical pharmacology studies — has been revised 12 years after it was first issued.
International Pharmaceutical Regulatory Monitor
International Pharmaceutical Regulatory Monitor
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May